Real-time enrollment status for this gi cancers clinical trial
Current Status
Recruiting
Checked: October 5, 2026 at 10:03 PM UTC
| NCT Number | NCT07216560 |
| Recruiting Status | Recruiting |
| Condition | GI Cancers |
| Phase | PHASE1 |
| Target Enrollment | 200 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Mabwell (Shanghai) Bioscience Co., Ltd. |
| Last Updated on CT.gov | August 21, 2026 (Aug 21, 2026) |
As of October 5, 2026: Clinical trial NCT07216560 is currently recruiting participants. This phase1 study for gi cancers is actively seeking new participants at 6 locations across the United States. The study is sponsored by Mabwell (Shanghai) Bioscience Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216560 is actively recruiting participants as of October 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216560 was last updated Aug 21, 2026 (August 21, 2026). HelloStudys verifies this status automatically.